The study will test the efficacy of drug eluting balloon(DEB) for non-atherosclerotic renal artery stenosis. The DEB (paclitaxel eluting balloon) will be used in the intervention group, while the plain old balloon(POB) will be used in the control group. The primary outcome is the effect of blood pressure control.
age between 18y and 45y.
with ≥ 60% stenosis in at least one renal artery.
with hypertension (systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥ 90 mmHg).
patients with no severe renal insufficiency (eGFR>30 ml/min, length of the kidney ≥ 7cm).
With apparent atherosclerotic risk factors.
With renal intervention or surgery history.
With congenital anatomical anomaly.
With severe renal insufficiency (length of the target kidney < 7cm, total
Parallel
Parallel Assignment
Procedure/Surgeryintervention group: treated with drug eluting balloon（paclitaxel-coated balloon； Orchid, Acotec Scientific Holdings Limited, Beijing, China)； control group :treated with plain old balloon
Primary patency rate
uninterrupted patency with no procedures performed on or at the margins of the treated segment or bypass
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
